AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26747317 — intervention group
Group type: EXPERIMENTAL
Intervention: SDQ mapping algorithm using three SDQ subscales
Number of subjects: 0
Study 26747317 — intervention group
Group type: EXPERIMENTAL
Intervention: Original CHU9D tariff
Number of subjects: 0
Study 26747317 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative CHU9D tariff
Number of subjects: 0
Study 24480603 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (moderate pressure stroking)
Number of subjects: 30
Study 24480603 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (flexion and extension of limbs)
Number of subjects: 30
Study 22128081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane use (experimental group)
Number of subjects: 64
Study 22128081 — intervention group
Group type: COMPARATOR
Intervention: No cane use (control group)
Number of subjects: 64
Study 20228679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glucagon‐like peptide‐1 (1.2 pmol/kg/min)
Number of subjects: 25
Study 17490508 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 36
Study 17490508 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 36
Study 16088097 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol + honey (0.5 g/kg + 1.25 ml/kg)
Number of subjects: 50
Study 16088097 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 50
Study 12149294 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 1,600 mg/d for 2 years
Number of subjects: 1069
Study 12149294 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 years
Number of subjects: 1069
Study 12149294 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 1069
Study 12149294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1069
Study 10235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (including 5-fluorouracil, gemcitabine)
Number of subjects: 0
Study 10235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 0
Study 10235081 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 0
Study 7869919 — intervention group
Group type: EXPERIMENTAL
Intervention: Three meals per day
Number of subjects: 12
Study 7869919 — intervention group
Group type: COMPARATOR
Intervention: Six meals per day
Number of subjects: 12
Study 2389321 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose)
Number of subjects: 33
Study 2389321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 363255 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy to the regional lymph node area following lymphadenectomy
Number of subjects: 56
Study 363255 — intervention group
Group type: COMPARATOR
Intervention: Lymphadenectomy alone
Number of subjects: 56
Study 31814045 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 6
Study 31814045 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam
Number of subjects: 6
Study 31814045 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged SLED-HDF (12 h)
Number of subjects: 6
Study 31530615 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective removal (SE)
Number of subjects: 115
Study 31530615 — intervention group
Group type: COMPARATOR
Intervention: Stepwise removal (SW)
Number of subjects: 115
Study 31530615 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective removal (SE) and Stepwise removal (SW)
Number of subjects: 115
Study 28236604 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompted Voiding (PV) intervention delivered by nursing home staff for 6 months
Number of subjects: 52
Study 28236604 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 52
Study 26168857 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/d lactotripeptides (LTP) and 2 g/d plant sterols
Number of subjects: 104
Study 26168857 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/d lactotripeptides (LTP) and 2 g/d plant sterols
Number of subjects: 104
Study 26168857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 24061556 — intervention group
Group type: EXPERIMENTAL
Intervention: Overt Hypothyroidism (OHT)
Number of subjects: 75
Study 24061556 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical Hypothyroidism (SHT)
Number of subjects: 75
Study 24061556 — intervention group
Group type: COMPARATOR
Intervention: Healthy Volunteers (Control)
Number of subjects: 75
Study 21861027 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand instrumentation with K‐Flexofiles
Number of subjects: 60
Study 21861027 — intervention group
Group type: EXPERIMENTAL
Intervention: K‐Flexofiles activated by an oscillatory system
Number of subjects: 60
Study 21861027 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper NiTi rotary system
Number of subjects: 60
Study 19672567 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day (n=13)
Number of subjects: 64
Study 19672567 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day + MPA 2.5 mg/day (n=14)
Number of subjects: 64
Study 19672567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day (n=11)
Number of subjects: 64
Study 19672567 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (n=9)
Number of subjects: 64
Study 19672567 — intervention group
Group type: COMPARATOR
Intervention: Control (n=17)
Number of subjects: 64
Study 17088163 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care for depression (12 months of systematic depression care including antidepressant pharmacotherapy and/or problem-solving treatment)
Number of subjects: 1001
Study 17088163 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 1001
Study 14751370 — intervention group
Group type: EXPERIMENTAL
Intervention: U-Tex
Number of subjects: 12
Study 14751370 — intervention group
Group type: EXPERIMENTAL
Intervention: C3
Number of subjects: 12
Study 14751370 — intervention group
Group type: EXPERIMENTAL
Intervention: Cunningham clamp
Number of subjects: 12
Study 11553203 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-prandial insulin lispro (PL)
Number of subjects: 24
Study 11553203 — intervention group
Group type: COMPARATOR
Intervention: Human regular insulin (HR)
Number of subjects: 24
Study 9593041 — intervention group
Group type: EXPERIMENTAL
Intervention: pyrimethamine-sulfadoxine
Number of subjects: 0
Study 9593041 — intervention group
Group type: COMPARATOR
Intervention: chlorproguanil-dapsone
Number of subjects: 0
Study 7869886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 300 mg.kg‐1
Number of subjects: 7
Study 7869886 — intervention group
Group type: COMPARATOR
Intervention: NaCl 207 mg.kg‐1
Number of subjects: 7
Study 3257532 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim (800 mg and 160 mg twice per day)
Number of subjects: 60
Study 3257532 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 60
Study 3257532 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim
Number of subjects: 60
Study 30320542 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous mutations in PAI-1, MTHFR A1298C, and ACE genes
Number of subjects: 102
Study 30320542 — intervention group
Group type: EXPERIMENTAL
Intervention: FXIII V34L and PAI-1 4G/5G genotypes
Number of subjects: 102
Study 30320542 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic, traditional, and total scores
Number of subjects: 102
Study 28615258 — intervention group
Group type: EXPERIMENTAL
Intervention: Package of health and nutrition interventions (lipid nutrient supplement, deworming medication, zinc supplementation, bed net, malaria chemoprophylaxis)
Number of subjects: 1383
Study 28615258 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine health and nutrition counseling only)
Number of subjects: 1383
Study 28615258 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 1383
Study 25783161 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone (40 μg twice daily)
Number of subjects: 288
Study 24025630 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat yogurt mixed with a fat-free aroma extract of olive oil
Number of subjects: 11
Study 24025630 — intervention group
Group type: COMPARATOR
Intervention: Plain low-fat yogurt
Number of subjects: 11
Study 21410628 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin plus pioglitazone (30 mg pioglitazone plus 5 mg linagliptin)
Number of subjects: 389
Study 21410628 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus pioglitazone (30 mg pioglitazone plus placebo)
Number of subjects: 389
Study 21410628 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin plus pioglitazone
Number of subjects: 389
Study 21410628 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus pioglitazone
Number of subjects: 389
Study 18376230 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative surgery
Number of subjects: 193
Study 18376230 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 193
Study 18376230 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 193
Study 18376230 — intervention group
Group type: COMPARATOR
Intervention: Overall cohort
Number of subjects: 193
Study 16391331 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 for 2 months followed by folic acid for 2 months
Number of subjects: 200
Study 16391331 — intervention group
Group type: COMPARATOR
Intervention: Folic acid for 2 months followed by vitamin B12 for 2 months
Number of subjects: 200
Study 12673681 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide MAGE‐A12:170‐178 administered subcutaneously in incomplete Freund's adjuvant (IFA), either every week or every 3 weeks for 4 cycles.
Number of subjects: 9
Study 12673681 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide MAGE‐A12:170‐178
Number of subjects: 9
Study 10780138 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy (CBT) - Coping with MS (CMS)
Number of subjects: 32
Study 10780138 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control (UCC)
Number of subjects: 32
Study 8776821 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 30 mg intravesical instillations weekly for 8 weeks, followed by monthly maintenance doses for 12 months
Number of subjects: 208
Study 8776821 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 208
Study 1346807 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 61
Study 1346807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 6844410 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal inspiratory breathing exercises
Number of subjects: 49
Study 6844410 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry
Number of subjects: 49
Study 6844410 — intervention group
Group type: COMPARATOR
Intervention: Early mobilization
Number of subjects: 49
Study 31985380 — intervention group
Group type: EXPERIMENTAL
Intervention: Maqliasa capsules (2 capsules t.i.d.) for 28 days
Number of subjects: 13
Study 30724658 — intervention group
Group type: EXPERIMENTAL
Intervention: JVC‐001
Number of subjects: 100
Study 30724658 — intervention group
Group type: COMPARATOR
Intervention: MR with monovalent mumps vaccine (Hoshino strain)
Number of subjects: 100
Study 29880238 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (100 mg daily)
Number of subjects: 101
Study 29880238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 29880238 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (continued treatment)
Number of subjects: 101
Study 29880238 — intervention group
Group type: COMPARATOR
Intervention: Placebo (switched from amisulpride)
Number of subjects: 101
Study 29880238 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 101
Study 27368062 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c criteria
Number of subjects: 17971
Study 27368062 — intervention group
Group type: COMPARATOR
Intervention: FPG criteria
Number of subjects: 17971
Study 27368062 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c alone
Number of subjects: 17971
Study 27368062 — intervention group
Group type: COMPARATOR
Intervention: FPG alone
Number of subjects: 17971
Study 27368062 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 17971
Study 27368062 — intervention group
Group type: COMPARATOR
Intervention: FPG
Number of subjects: 17971
Study 24722047 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 30
Study 24722047 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 30
Study 24722047 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin type A
Number of subjects: 30
Study 22491507 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing a training video on empowerment
Number of subjects: 43
Study 22491507 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 43
Study 20563965 — intervention group
Group type: EXPERIMENTAL
Intervention: DemTect-B
Number of subjects: 80
Study 20563965 — intervention group
Group type: COMPARATOR
Intervention: DemTect-A
Number of subjects: 80
Study 17036029 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral erythromycin 1 mg/kg every 8 h
Number of subjects: 60
Study 17036029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study 15766294 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 384
Study 16920758 — intervention group
Group type: EXPERIMENTAL
Intervention: TV group (passive distraction with a TV cartoon)
Number of subjects: 69
Study 16920758 — intervention group
Group type: EXPERIMENTAL
Intervention: M group (active distraction by mothers)
Number of subjects: 69
Study 16920758 — intervention group
Group type: COMPARATOR
Intervention: C group (control without distraction)
Number of subjects: 69
Study 11134689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient odor of orange
Number of subjects: 72
Study 11134689 — intervention group
Group type: COMPARATOR
Intervention: No odor (control group)
Number of subjects: 72
Study 9156785 — intervention group
Group type: EXPERIMENTAL
Intervention: TCV-309 (1.0 mg/kg twice daily for 7 days)
Number of subjects: 29
Study 9156785 — intervention group
Group type: EXPERIMENTAL
Intervention: TCV-309
Number of subjects: 29
Study 9156785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 1638191 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 79
Study 1638191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 6240787 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of spectinomycin intramuscularly
Number of subjects: 200
Study 6240787 — intervention group
Group type: COMPARATOR
Intervention: 2.5 g of thiamphenicol (500 mg intramuscularly after oral 2 g)
Number of subjects: 200
Study 30472681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride (1-5 mg/kg)
Number of subjects: 30
Study 30472681 — intervention group
Group type: COMPARATOR
Intervention: Abdominal VNS
Number of subjects: 30
Study 30472681 — intervention group
Group type: COMPARATOR
Intervention: Sham/Placebo
Number of subjects: 30
Study 29364495 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum P17630 (5x10^9 CFU/capsule)
Number of subjects: 93
Study 29364495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 25609451 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent 3D-CRT/IMRT plus FOLFOX regimen
Number of subjects: 110
Study 23851593 — intervention group
Group type: EXPERIMENTAL
Intervention: Predefined biochemical profile
Number of subjects: 191
Study 23851593 — intervention group
Group type: COMPARATOR
Intervention: Physician discretion
Number of subjects: 191
Study 22648705 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 59
Study 20435876 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfracture
Number of subjects: 0
Study 20435876 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteochondral autograft transfer
Number of subjects: 0
Study 20435876 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation
Number of subjects: 0
Study 20435876 — intervention group
Group type: COMPARATOR
Intervention: Surgical interventions
Number of subjects: 0
Study 18833117 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (strattera) in daily dosage 0.8‐1.2 mg/kg as a monotherapy for 6 weeks
Number of subjects: 42
Study 18833117 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam as a monotherapy in daily dosage 50‐70 mg/kg for 6 weeks
Number of subjects: 42
Study 18833117 — intervention group
Group type: COMPARATOR
Intervention: No pharmacological therapy
Number of subjects: 42
Study 16019374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomeroy technique tubal ligation
Number of subjects: 108
Study 16019374 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched women)
Number of subjects: 108
Study 11921128 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension (2.5 mg doses)
Number of subjects: 40
Study 11921128 — intervention group
Group type: COMPARATOR
Intervention: Tablet (25 mg doses)
Number of subjects: 40
Study 9885797 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (acute treatment)
Number of subjects: 0
Study 9885797 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (chronic administration)
Number of subjects: 0
Study 7720151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms.kg‐1 before induction of anaesthesia (FA)
Number of subjects: 85
Study 7720151 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 1 micrograms.kg‐1 before induction of anaesthesia (SA)
Number of subjects: 85
Study 7720151 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl after removal of the uterus (FC)
Number of subjects: 85
Study 7720151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl after peritoneal incision (FB)
Number of subjects: 85
Study 30737622 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-thickness skin graft (FTSG)
Number of subjects: 52
Study 30737622 — intervention group
Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 52
Study 28707173 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually adjusted PEEP levels
Number of subjects: 37
Study 28707173 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilator regimen
Number of subjects: 37
Study 27452327 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 170
Study 27452327 — intervention group
Group type: COMPARATOR
Intervention: Non-dippers (NT-ND)
Number of subjects: 170
Study 27452327 — intervention group
Group type: COMPARATOR
Intervention: Non-dippers (HT-ND)
Number of subjects: 170
Study 25365688 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity induction
Number of subjects: 0
Study 25365688 — intervention group
Group type: COMPARATOR
Intervention: Control induction
Number of subjects: 0
Study 22320335 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the availability of lower-calorie products in vending machines
Number of subjects: 28
Study 22320335 — intervention group
Group type: EXPERIMENTAL
Intervention: Labeling products
Number of subjects: 28
Study 22320335 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing the price of lower-calorie products
Number of subjects: 28
Study 22320335 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of availability, labeling, and price reduction
Number of subjects: 28
Study 22320335 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 28
Study 18806910 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) and lifestyle advice (n = 23)
Number of subjects: 47
Study 18806910 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a lifestyle advice sheet (n = 24)
Number of subjects: 47
Study 17710290 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + EMP
Number of subjects: 13
Study 17710290 — intervention group
Group type: COMPARATOR
Intervention: OFD
Number of subjects: 13
Study 15190044 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with mixed fruit and vegetable juice concentrates
Number of subjects: 59
Study 15190044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 11593992 — intervention group
Group type: EXPERIMENTAL
Intervention: Press-coated, time-controlled release tablets containing pseudoephedrine hydrochloride
Number of subjects: 8
Study 9519217 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo-osmolar aerosol (ultrasonically nebulized distilled water, output 2 ml/min-1)
Number of subjects: 24
Study 9519217 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 24
Study 7863140 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal application of Lactobacillus casei v. rhamnosus twice weekly
Number of subjects: 47
Study 7863140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 2692521 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide (CO) exposure
Number of subjects: 24
Study 2692521 — intervention group
Group type: COMPARATOR
Intervention: Clean air exposure
Number of subjects: 24
Study 1108645 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication during hospitalization and as an outpatient
Number of subjects: 48
Study 1108645 — intervention group
Group type: COMPARATOR
Intervention: Traditional drug administration during hospitalization and self-medication as an outpatient
Number of subjects: 48
Study 31983494 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron
Number of subjects: 436
Study 31983494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study 31983494 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 436